Results 131 to 140 of about 55,913 (304)

Immunogenicity and Efficacy of Different Haemophilus influenzae type b Vaccines

Archives of Razi Institute, 2014
Haemophilus influenzae, a major cause of meningitis in young children leading to death and other neurological sequelae. The disease leaves 15 to 35% of the survivors with permanent disabilities, such as, mental retardation or deafness.
Mojgani, N.
doaj  

Current safety issues with quadrivalent meningococcal conjugate vaccines

Human Vaccines & Immunotherapeutics, 2018
Invasive meningococcal disease, although rare, can present as sudden, life-threatening disease with high risk of mortality or severe long-term sequelae.
Tanya R. Myers, Michael M. McNeil
doaj   +1 more source

A Three Component Synthetic Vaccine Containing a β-Mannan T-Cell Peptide Epitope and a β-Glucan Dendritic Cell Ligand

Molecules, 2018
Glycoconjugates prepared from the capsular polysaccharide of several pathogenic bacteria and carrier proteins, such as CRM 197 or tetanus toxoid, have been one of the most successful public health measures to be implemented in the last quarter century. A
David R. Bundle, Eugenia Paszkiewicz, Hassan R. H. Elsaidi, Satadru Sekhar Mandal, Susmita Sarkar   +4 more
doaj   +1 more source

17. HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE (PRP-D) PROTECTS FROM BACTEREMIC DISEASES IN INFANCY [PDF]

, 1988
Juhani Eskola, Aino K. Takala, Hejkki Peltola, Helena Käyhty, Helena Mäkelä   +4 more
openalex   +1 more source

The Update, February 13, 2012 [PDF]

, 2012
The Update is a bi-weekly web newsletter published by the Iowa Department of Public Health's Bureau of Family Health. It is posted the second and fourth week of every month, and provides useful job resource information for departmental health care ...

core  

Universal Prophylactic Antitumor Vaccination Using Stem Cell Membrane‐Coated Nanoparticles

Advanced Materials, Volume 37, Issue 14, April 9, 2025.
Induced pluripotent stem cell membrane is coated onto adjuvant‐loaded nanoparticle cores to create a universal cancer vaccine. The formulation utilizes oncofetal antigens present on the cell membrane to elicit broadly protective immune responses in vivo.
Nishta Krishnan, Jiarong Zhou, Animesh Mohapatra, Christian John Ventura, Yaou Duan, Junyong Lee, Jacob J. Hoenig, Oliver Nizet, Weiwei Gao, Ronnie H. Fang, Liangfang Zhang   +10 more
wiley   +1 more source

Design of a Glycoconjugate Vaccine Against Salmonella Paratyphi A

Vaccines
Background/Objectives: Typhoid and paratyphoid fever together are responsible for millions of cases and thousands of deaths per year, most of which occur in children in South and Southeast Asia.
Renzo Alfini, Martina Carducci, Luisa Massai, Daniele De Simone, Marco Mariti, Omar Rossi, Simona Rondini, Francesca Micoli, Carlo Giannelli   +8 more
doaj   +1 more source

An evaluation of emerging vaccines for childhood meningococcal disease

BMC Public Health, 2011
Background Meningococcal meningitis is a major cause of disease worldwide, with frequent epidemics particularly affecting an area of sub-Saharan Africa known as the “meningitis belt”.
Nelson Christopher B, El Arifeen Shams, Zhang Jian Shayne F, Johnson Hope L, Luksic Ivana, Falconer Rachel, Zgaga Lina, Nair Harish, Theodoratou Evropi, Huda Tanvir, Choudhuri Debajeet, Borrow Ray, Campbell Harry, Rudan Igor   +13 more
doaj   +1 more source

ADULT-LIKE ANTIBODY (Ab) RESPONSES TO HAEMOPHILUS INFLUENZAE b (HIB) CAPSULAR POLYSACCHARIDE (PRP) VACCINE IN HUMAN INFANTS PRIMED WITH PROTEIN-OLIGOSACCHARIDE CONJUGATE VACCINES [PDF]

, 1987
Michael E. Pichichero, Richard A. Insel, Porter Anderson   +2 more
openalex   +1 more source

Adjusting Cell‐Surface Interactions Through a Covalent Immobilization of Biomolecules

Advanced Materials Interfaces, EarlyView.
This review presents an overview of current and emerging immobilization techniques coupled with an in‐depth investigation of the underlying mechanisms governing the activity and stability of covalently immobilized biomolecules. The aim of this study is to serve as a guide for the development of long‐lasting biomedical coatings with versatile biological
Sara Shakibania, Manus J. P. Biggs, Katarzyna Krukiewicz   +2 more
wiley   +1 more source